Which non-steroidal anti-inflammatory drug (NSAID) is safer in patients with Non-steroids Exacerbated Respiratory Disease (N-ERD)? A single-center retrospective study
CONCLUSIONS: Selective COX-2 inhibitor NSAIDs are safe in patients with N-ERD. NSAIDs should be prescribed to these patients following general medical precautions and drug challenge tests.PMID:36537094 | DOI:10.5578/tt.20229608 (Source: Tuberkuloz ve Toraks)
Source: Tuberkuloz ve Toraks - December 20, 2022 Category: Respiratory Medicine Authors: Mehmet Erdem Çakmak Source Type: research
Which non-steroidal anti-inflammatory drug (NSAID) is safer in patients with Non-steroids Exacerbated Respiratory Disease (N-ERD)? A single-center retrospective study
CONCLUSIONS: Selective COX-2 inhibitor NSAIDs are safe in patients with N-ERD. NSAIDs should be prescribed to these patients following general medical precautions and drug challenge tests.PMID:36537094 | DOI:10.5578/tt.20229608 (Source: Tuberkuloz ve Toraks)
Source: Tuberkuloz ve Toraks - December 20, 2022 Category: Respiratory Medicine Authors: Mehmet Erdem Çakmak Source Type: research
Which non-steroidal anti-inflammatory drug (NSAID) is safer in patients with Non-steroids Exacerbated Respiratory Disease (N-ERD)? A single-center retrospective study
CONCLUSIONS: Selective COX-2 inhibitor NSAIDs are safe in patients with N-ERD. NSAIDs should be prescribed to these patients following general medical precautions and drug challenge tests.PMID:36537094 | DOI:10.5578/tt.20229608 (Source: Tuberkuloz ve Toraks)
Source: Tuberkuloz ve Toraks - December 20, 2022 Category: Respiratory Medicine Authors: Mehmet Erdem Çakmak Source Type: research
Which non-steroidal anti-inflammatory drug (NSAID) is safer in patients with Non-steroids Exacerbated Respiratory Disease (N-ERD)? A single-center retrospective study
CONCLUSIONS: Selective COX-2 inhibitor NSAIDs are safe in patients with N-ERD. NSAIDs should be prescribed to these patients following general medical precautions and drug challenge tests.PMID:36537094 | DOI:10.5578/tt.20229608 (Source: Tuberkuloz ve Toraks)
Source: Tuberkuloz ve Toraks - December 20, 2022 Category: Respiratory Medicine Authors: Mehmet Erdem Çakmak Source Type: research
Which non-steroidal anti-inflammatory drug (NSAID) is safer in patients with Non-steroids Exacerbated Respiratory Disease (N-ERD)? A single-center retrospective study
CONCLUSIONS: Selective COX-2 inhibitor NSAIDs are safe in patients with N-ERD. NSAIDs should be prescribed to these patients following general medical precautions and drug challenge tests.PMID:36537094 | DOI:10.5578/tt.20229608 (Source: Tuberkuloz ve Toraks)
Source: Tuberkuloz ve Toraks - December 20, 2022 Category: Respiratory Medicine Authors: Mehmet Erdem Çakmak Source Type: research
Which non-steroidal anti-inflammatory drug (NSAID) is safer in patients with Non-steroids Exacerbated Respiratory Disease (N-ERD)? A single-center retrospective study
CONCLUSIONS: Selective COX-2 inhibitor NSAIDs are safe in patients with N-ERD. NSAIDs should be prescribed to these patients following general medical precautions and drug challenge tests.PMID:36537094 | DOI:10.5578/tt.20229608 (Source: Tuberkuloz ve Toraks)
Source: Tuberkuloz ve Toraks - December 20, 2022 Category: Respiratory Medicine Authors: Mehmet Erdem Çakmak Source Type: research
Which non-steroidal anti-inflammatory drug (NSAID) is safer in patients with Non-steroids Exacerbated Respiratory Disease (N-ERD)? A single-center retrospective study
CONCLUSIONS: Selective COX-2 inhibitor NSAIDs are safe in patients with N-ERD. NSAIDs should be prescribed to these patients following general medical precautions and drug challenge tests.PMID:36537094 | DOI:10.5578/tt.20229608 (Source: Tuberkuloz ve Toraks)
Source: Tuberkuloz ve Toraks - December 20, 2022 Category: Respiratory Medicine Authors: Mehmet Erdem Çakmak Source Type: research
Which non-steroidal anti-inflammatory drug (NSAID) is safer in patients with Non-steroids Exacerbated Respiratory Disease (N-ERD)? A single-center retrospective study
CONCLUSIONS: Selective COX-2 inhibitor NSAIDs are safe in patients with N-ERD. NSAIDs should be prescribed to these patients following general medical precautions and drug challenge tests.PMID:36537094 | DOI:10.5578/tt.20229608 (Source: Tuberkuloz ve Toraks)
Source: Tuberkuloz ve Toraks - December 20, 2022 Category: Respiratory Medicine Authors: Mehmet Erdem Çakmak Source Type: research
Which non-steroidal anti-inflammatory drug (NSAID) is safer in patients with Non-steroids Exacerbated Respiratory Disease (N-ERD)? A single-center retrospective study
CONCLUSIONS: Selective COX-2 inhibitor NSAIDs are safe in patients with N-ERD. NSAIDs should be prescribed to these patients following general medical precautions and drug challenge tests.PMID:36537094 | DOI:10.5578/tt.20229608 (Source: Tuberkuloz ve Toraks)
Source: Tuberkuloz ve Toraks - December 20, 2022 Category: Respiratory Medicine Authors: Mehmet Erdem Çakmak Source Type: research
Which non-steroidal anti-inflammatory drug (NSAID) is safer in patients with Non-steroids Exacerbated Respiratory Disease (N-ERD)? A single-center retrospective study
CONCLUSIONS: Selective COX-2 inhibitor NSAIDs are safe in patients with N-ERD. NSAIDs should be prescribed to these patients following general medical precautions and drug challenge tests.PMID:36537094 | DOI:10.5578/tt.20229608 (Source: Tuberkuloz ve Toraks)
Source: Tuberkuloz ve Toraks - December 20, 2022 Category: Respiratory Medicine Authors: Mehmet Erdem Çakmak Source Type: research
Which non-steroidal anti-inflammatory drug (NSAID) is safer in patients with Non-steroids Exacerbated Respiratory Disease (N-ERD)? A single-center retrospective study
CONCLUSIONS: Selective COX-2 inhibitor NSAIDs are safe in patients with N-ERD. NSAIDs should be prescribed to these patients following general medical precautions and drug challenge tests.PMID:36537094 | DOI:10.5578/tt.20229608 (Source: Tuberkuloz ve Toraks)
Source: Tuberkuloz ve Toraks - December 20, 2022 Category: Respiratory Medicine Authors: Mehmet Erdem Çakmak Source Type: research
Which non-steroidal anti-inflammatory drug (NSAID) is safer in patients with Non-steroids Exacerbated Respiratory Disease (N-ERD)? A single-center retrospective study
CONCLUSIONS: Selective COX-2 inhibitor NSAIDs are safe in patients with N-ERD. NSAIDs should be prescribed to these patients following general medical precautions and drug challenge tests.PMID:36537094 | DOI:10.5578/tt.20229608 (Source: Tuberkuloz ve Toraks)
Source: Tuberkuloz ve Toraks - December 20, 2022 Category: Respiratory Medicine Authors: Mehmet Erdem Çakmak Source Type: research
Which non-steroidal anti-inflammatory drug (NSAID) is safer in patients with Non-steroids Exacerbated Respiratory Disease (N-ERD)? A single-center retrospective study
CONCLUSIONS: Selective COX-2 inhibitor NSAIDs are safe in patients with N-ERD. NSAIDs should be prescribed to these patients following general medical precautions and drug challenge tests.PMID:36537094 | DOI:10.5578/tt.20229608 (Source: Tuberkuloz ve Toraks)
Source: Tuberkuloz ve Toraks - December 20, 2022 Category: Respiratory Medicine Authors: Mehmet Erdem Çakmak Source Type: research
Which non-steroidal anti-inflammatory drug (NSAID) is safer in patients with Non-steroids Exacerbated Respiratory Disease (N-ERD)? A single-center retrospective study
CONCLUSIONS: Selective COX-2 inhibitor NSAIDs are safe in patients with N-ERD. NSAIDs should be prescribed to these patients following general medical precautions and drug challenge tests.PMID:36537094 | DOI:10.5578/tt.20229608 (Source: Tuberkuloz ve Toraks)
Source: Tuberkuloz ve Toraks - December 20, 2022 Category: Respiratory Medicine Authors: Mehmet Erdem Çakmak Source Type: research
Which non-steroidal anti-inflammatory drug (NSAID) is safer in patients with Non-steroids Exacerbated Respiratory Disease (N-ERD)? A single-center retrospective study
CONCLUSIONS: Selective COX-2 inhibitor NSAIDs are safe in patients with N-ERD. NSAIDs should be prescribed to these patients following general medical precautions and drug challenge tests.PMID:36537094 | DOI:10.5578/tt.20229608 (Source: Tuberkuloz ve Toraks)
Source: Tuberkuloz ve Toraks - December 20, 2022 Category: Respiratory Medicine Authors: Mehmet Erdem Çakmak Source Type: research
